MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.
复制标题

DOI:
10.1038/nrd3864
复制
发表时间:
2012-11
期刊:
Nature reviews. Drug discovery
影响因子:
--
通讯作者:
Olson EN
Olson EN
中科院分区:
其他
文献类型:
--
作者:
van Rooij E;Olson EN

文献摘要

参考文献

被引文献

相似文献

近年来,microRNA(miRNAs)在几种心血管疾病中的重要作用已被发现。通过全身或局部递送miRNA抑制剂(称为antimiR)来治疗性操纵miRNA表达和功能的能力已经引发了对miRNA作为新的治疗靶点的热情。在这里,我们专注于当前antimiR设计的药代动力学和药效学特性及其与心血管适应症的相关性,并评估与这种新的治疗方式相关的机会和障碍。
In recent years, prominent roles for microRNAs (miRNAs) have been uncovered in several cardiovascular disorders. The ability to therapeutically manipulate miRNA expression and function through systemic or local delivery of miRNA inhibitors, referred to as antimiRs, has triggered enthusiasm for miRNAs as novel therapeutic targets. Here, we focus on the pharmacokinetic and pharmacodynamic properties of current antimiR designs and their relevance to cardiovascular indications, and evaluate the opportunities and obstacles associated with this new therapeutic modality.
DOI: 10.1038/nature07242
发表时间: 2008-09-04
期刊: NATURE
影响因子: 64.8
作者:
Baek, Daehyun;Villen, Judit;Shin, Chanseok;Camargo, Fernando D.;Gygi, Steven P.;Bartel, David P.
通讯作者: Bartel, David P.
DOI: 10.1165/rcmb.2010-0323oc
发表时间: 2011-08-01
影响因子: 6.4
作者:
Cushing, Leah;Kuang, Ping Ping;Lue, Jining
通讯作者: Lue, Jining
DOI: 10.1161/circresaha.112.267443
发表时间: 2012-08-03
影响因子: 20.1
作者:
Corsten, Maarten F.;Papageorgiou, Anna;Heymans, Stephane
通讯作者: Heymans, Stephane
DOI: 10.1002/emmm.201100171
发表时间: 2011-10
影响因子: 11.1
作者:
Garchow, Barry G.;Encinas, Oscar Bartulos;Leung, Yiu Tak;Tsao, Patricia Y.;Eisenberg, Robert A.;Caricchio, Roberto;Obad, Susanna;Petri, Andreas;Kauppinen, Sakari;Kiriakidou, Marianthi
通讯作者: Kiriakidou, Marianthi
DOI: 10.1161/circresaha.112.267591
发表时间: 2012-07-20
影响因子: 20.1
作者:
Caruso, Paola;Dempsie, Yvonne;Baker, Andrew H.
通讯作者: Baker, Andrew H.